3 search results for: fev1

Why Is It Important to Assess Lung Function in Pediatric Asthma
interactivity

Why Is It Important to Assess Lung Function in Pediatric Asthma

Pulmonology
Learn about FEV1pp and the downstream effects of lung function decline in children with severe asthma
View more
Monitoring Lung Function Is an Important Aspect of Pediatric Asthma Management
interactivity

Monitoring Lung Function Is an Important Aspect of Pediatric Asthma Management

Pulmonology
Navigate through this interactive infographic to learn more about why lung function is important to monitor in pediatric patients with asthma and the noninvasive procedures that are available for implementation in clinical practice.
View more
Expert Insights: Importance of Lung Function Assessment in Pediatric Asthma Patients
expert video

Expert Insights: Importance of Lung Function Assessment in Pediatric Asthma Patients

Pulmonology
Dr. Michael Blaiss describes the importance of lung function assessment in pediatric asthma management
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ChinaChange country/region